Company intelligence / Profile preview

VesCir

Taipei, T'ai-pei/Taipei City, Taiwandnb.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

VesCir has developed the iCi dynamic skincare system that uses AI and biotechnology to deliver personalized skin care solutions. The company’s technology collects data from users’ skin to tailor product recommendations and formulations. The iCi system won the Best Brand and Retail Product at LVMH Group's Cosmetic 360 Awards in 2019. It was featured as a top Taiwanese startup at CES 2021.

Therapeutic areas: Dermatology
Modalities: DeviceAI-driven skincare systemWearable device
Industry: Physiological Monitoring

Drug pipeline

1 asset

Premiere

Commercial

Indications: Skincare

Partnerships

LVMH Group/Cosmetic360 Award recognition

Beyond the preview

Go deeper on VesCir.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VesCir.

Explore the full profile